Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Meyfroidt

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Neurocritical Care|July 27, 2022
Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based ConsensusFrank A Rasulo, Philip Hopkins, Francisco A Lobo, et al.
Journal of Neurotrauma|August 18, 2021
Targeting Autoregulation-Guided Cerebral Perfusion Pressure after Traumatic Brain Injury (COGiTATE): A Feasibility Randomized Controlled Clinical TrialJeanette Tas, Erta Beqiri, Ruud C van Kaam, et al.
Intensive Care Medicine|June 20, 2022
Correction to: Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Intensive Care Medicine|May 20, 2022
Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Intensive Care Medicine|June 10, 2020
Managing ICU surge during the COVID-19 crisis: rapid guidelinesShadman Aziz, Yaseen M Arabi, Waleed Alhazzani, et al.
Neurocritical Care|December 2, 2024
Does Targeting CPP at CPPopt Actually Improve Cerebrovascular Reactivity? A Secondary Analysis of the COGiTATE Randomized Controlled TrialErta Beqiri, Jeanette Tas, Marek Czosnyka, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Trials|December 15, 2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The Lancet. Respiratory Medicine|December 4, 2020
Successful double-lung transplantation from a donor previously infected with SARS-CoV-2Laurens J Ceulemans, Jan Van Slambrouck, Paul De Leyn, et al.
Critical Care (London, England)|April 22, 2015
Neuroprotection in acute brain injury: an up-to-date reviewNino Stocchetti, Fabio S Taccone, Giuseppe Citerio, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Neurocritical Care|July 27, 2022
Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based ConsensusFrank A Rasulo, Philip Hopkins, Francisco A Lobo, et al.
Journal of Neurotrauma|August 18, 2021
Targeting Autoregulation-Guided Cerebral Perfusion Pressure after Traumatic Brain Injury (COGiTATE): A Feasibility Randomized Controlled Clinical TrialJeanette Tas, Erta Beqiri, Ruud C van Kaam, et al.
Intensive Care Medicine|June 20, 2022
Correction to: Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Intensive Care Medicine|May 20, 2022
Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Intensive Care Medicine|June 10, 2020
Managing ICU surge during the COVID-19 crisis: rapid guidelinesShadman Aziz, Yaseen M Arabi, Waleed Alhazzani, et al.
Neurocritical Care|December 2, 2024
Does Targeting CPP at CPPopt Actually Improve Cerebrovascular Reactivity? A Secondary Analysis of the COGiTATE Randomized Controlled TrialErta Beqiri, Jeanette Tas, Marek Czosnyka, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Trials|December 15, 2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The Lancet. Respiratory Medicine|December 4, 2020
Successful double-lung transplantation from a donor previously infected with SARS-CoV-2Laurens J Ceulemans, Jan Van Slambrouck, Paul De Leyn, et al.
Critical Care (London, England)|April 22, 2015
Neuroprotection in acute brain injury: an up-to-date reviewNino Stocchetti, Fabio S Taccone, Giuseppe Citerio, et al.
Pageof 18